Cell-Based Assays Market is expected to reach US$ 25.70 Bn. at a CAGR of 8.1 during the forecast period 2029.Global Cell-Based Assays Market Overview:
In life science research, cell-based assays are vital experiments. These assays are based on cell culture methods, where live cells grown in vitro and then used as a model system to analyze the physiology and biochemistry of both healthy and diseased cells. In the cell-based assay technique, functional cells are used as a diagnostic tool in the discovery of new drugs. Both standardized and custom-made cell-based assays are commonly used by scientists in a variety of applications as cost-effective and reproducible research methods.The Global Cell-Based Assays market report is a comprehensive analysis of the industry, market, and key players. This ranges from a macro overview of market segments by product and application with a competitive landscape.To know about the Research Methodology :- Request Free Sample Report
Global Cell-Based Assays Market Dynamics:
Driver: Growing preferences for cell-based assays over biochemical assays in drug discovery In the drug discovery and development process, cell-based assays are used as a vital component. In comparison to in vitro biochemical assays, cell-based assays have several benefits. In contrast to biochemical assays, they provide consistent tissue-specific responses in a biologically appropriate microenvironment. Also, not every target for biochemical measurement can be prepared or purified, which is a major factor restricting biochemical assay applications. As a result, pharmaceutical and biotechnology firms, as well as contract research organizations (CROs), are replacing biochemical assays with cell-based assays in their drug discovery lead detection and optimization processes. Modern cell-based assays combine the benefits of cell cultures and animal models to enable researchers to recognize problems with lead compounds early in the drug discovery and development process, resulting in increased performance. Moreover, cell-based assays' physiological relevance, as well as their ability to provide reliable, cost-effective, and accelerated drug discovery solutions, have fueled their increased adoption among end users.Restraint: Limitations on reagent use and high cost of instruments
Factors limiting the market: product end-user licenses limit the use of reagent kits to some assays. Customers are also limited to using only certain reagents listed in the license agreement, even though better and superior reagents are available on the market. This may be a stumbling block for the cell-based assays market's expansion. Owing to budget constraints, academic research laboratories are unable to purchase such costly instruments. The average cost of ownership of these instruments rises as a result of maintenance costs and other indirect expenses. High-throughput screening (HTS) and high-content screening (HCS) technologies have improved the reliability of cell-based assays. However, these technologies led to a significant increase in the cost of instruments. Also, the cost and time involved in these processes are proportional to the target molecules' complexity. However, severe intellectual property rights, and a lack of skilled professionals are restraining the expansion of the cell-based assays market.Opportunity: Markets in transition
Due to low labor and raw material costs, risk of pandemics (such as swine flu and COVID-19), growth in the number of research activities, and technological advances in the end-use sectors for cell-based assays in these countries, emerging Asian countries are expected to provide significant growth opportunities for players in the cell-based assays market. The Global Health Innovative Technology (GHIT) Fund, for example, is a public-private collaboration in Japan that supports various R&D initiatives for drug discovery, including compound library screening for various infectious diseases. According to World Bank figures, R&D investment in developing economies in Asia and the Rest of the World has exceeded that of North America and Europe. Additionally, the growing number of pharmaceutical companies and contract research organizations (CROs) key end-users of cell-based assays—in these countries is expected to provide future growth opportunities for cell-based assay manufacturers.Global Cell-Based Assays Market Segment Analysis:
Based on Product, the consumables segment has the largest market share and is expected to grow at the fastest rate over the forecast period. The growing number of drug discovery activities, especially in emerging markets, and repeated purchase of consumables by pharmaceutical and biopharmaceutical companies are one of the factors that can be attributed to the segment's growth. Based on Application, the drug discovery segment dominates the global cell-based market, holding the largest share. The drug discovery segment is expected to develop rapidly in the industry, owing to biopharmaceutical companies' increased R&D spending. Furthermore, the rising prevalence of chronic diseases like cancer, osteoarthritis, cardiovascular disease, and diabetes is boosting demand for cell-based assays for newer drug discoveries, making it a critical factor in the market's development. Functional cells are used as diagnostic instruments in research for new drugs in cell-based assays, which aid in drug discovery. Based on End Users, pharmaceutical and biotechnology firms dominated the industry, in 2021. Pharmaceutical and biopharmaceutical firms, contract research organizations (CROs), and academic and research institutes make up the cell-based assays industry.Global Cell-Based Assays Market Regional Insights:
Because of rising government initiatives and investment in cancer research, increased acceptance of cell-based assay platforms, and a large number of pharmaceutical and biotechnology companies in the area, North America is the leading region in terms of market share around the world followed by Europe, in 2021. The prevalence of chronic diseases such as cancer, osteoarthritis, and diabetes are rising in the United States, which is boosting demand for cell-based assays for newer drug discoveries, making it a critical factor in the market's development. Canada is quickly growing after the United States in the region. According to the American Cancer Society, approximately 1.9 million new cancer cases will be registered in the United States in 2021. Increasing approvals for stem cell therapy clinical trials are propelling the cell-based assays market forward. However, due to technological advancements and increased R&D activities in life science, increasing infrastructural development, and drug activities, Asia-Pacific is expected to be the fastest-growing region. The Chinese market is expected to dominate the Asia Pacific market for cell-based assays. During the study period, countries such as India and Japan were thought to have the highest levels. The Chinese market is expected to dominate the Asia Pacific market for cell-based assays. During the study period, countries such as India and Japan were thought to have the highest levels. Over the forecast era, they would increase the number of chronic diseases and the acquisition of extraordinary research facilities. The objective of the report is to present a comprehensive analysis of the global cell-based assays market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global cell-based assays market dynamics, structure by analyzing the market segments and project the global cell-based assays market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global cell-based assays market make the report investor’s guide.Global Cell-Based Assays Market Key Developments:
In 2021, Danaher Company launched ClearLLAb 10C System for Flow cytometry labs. In 2021, PerkinElmer completed the acquisition of Cisbio Bioassays.Global Cell-Based Assays Market Scope: Inquire before buying
Global Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 13.78 Bn. Forecast Period 2022 to 2029 CAGR: 8.1% Market Size in 2029: US $ 25.70 Bn. Segments Covered: by Product • Consumables • Reagents • Kits • Cell Lines • Primary Cell Lines • Stem Cell Lines • Immortalized Cell Lines • Microplates • Probes & Labels • Instruments • Services • Software • Others by Application • ADME Process • Drug Discovery • Predictive Toxicology • Others by End users • Pharmaceutical & Biotechnology Companies • Research Organizations • Government & Academic Institutes • Others Global Cell-Based Assays Market, by Region
• North America • Europe • Asia Pacific • South America • The Middle East and AfricaGlobal Cell-Based Assays Market Key Players
• DiscoverX Corporation • Becton • Dickison and Company • Bio-Rad Laboratories, Inc. • Corning Inc. • Merck KGaA • Cell Signalling Technology Inc. • Danaher Corporation • Thermo Fisher Scientific Inc. • Cisbio Bioassays • PerkinElmer Inc. • Cell Biolabs Inc. • Macrogen Inc. • Promega Corporation • Lonza Group Ltd. • Other Key PlayersFrequently Asked Questions:
1. Which region has the largest share in Global Cell-Based Assays Market? Ans: North America region holds the highest share in 2021. 2. What is the growth rate of Global Cell-Based Assays Market? Ans: The Global Cell-Based Assays Market is growing at a CAGR of 8.1% during forecasting period 2022-2029. 3. What is scope of the Global Cell-Based Assays market report? Ans: Global Cell-Based Assays Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Cell-Based Assays market? Ans: The important key players in the Global Cell-Based Assays Market are – DiscoverX Corporation, Becton, Dickison and Company, Bio-Rad Laboratories, Inc., Corning Inc., Merck KGaA, Cell Signalling Technology Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Cisbio Bioassays, PerkinElmer Inc., Cell Biolabs Inc., Macrogen Inc., Promega Corporation, Lonza Group Ltd., and Other Key Players 5. What is the study period of this market? Ans: The Global Cell-Based Assays Market is studied from 2021 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Cell-Based Assays Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Flow Cytometry Products Market 3.4. Geographical Snapshot of the Flow Cytometry Products Market, By Manufacturer share 4. Global Cell-Based Assays Market Overview, 2021-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Flow Cytometry Products Market 5. Supply Side and Demand Side Indicators 6. Global Cell-Based Assays Market Analysis and Forecast, 2021-2029 6.1. Global Cell-Based Assays Market Size & Y-o-Y Growth Analysis. 7. Global Cell-Based Assays Market Analysis and Forecasts, 2021-2029 7.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 7.1.1. Consumables 7.1.1.1. Reagents 7.1.1.2. Kits 7.1.2. Cell Lines 7.1.2.1. Primary Cell Lines 7.1.2.2. Stem Cell Lines 7.1.2.3. Immortalized Cell Lines 7.1.3. Microplates 7.1.4. Probes & Labels 7.1.5. Instruments 7.1.6. Services 7.1.7. Software 7.1.8. Others 7.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 7.2.1. ADME Process 7.2.2. Drug Discovery 7.2.3. Predictive Toxicology 7.2.4. Others 7.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 7.3.1. Pharmaceutical & Biotechnology Companies 7.3.2. Research Organizations 7.3.3. Government & Academic Institutes 7.3.4. Others 8. Global Cell-Based Assays Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Cell-Based Assays Market Analysis and Forecasts, 2021-2029 9.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 9.1.1. Consumables 9.1.2. Cell Lines 9.1.3. Microplates 9.1.4. Probes & Labels 9.1.5. Instruments 9.1.6. Software 9.1.7. Others 9.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 9.2.1. ADME Process 9.2.2. Drug Discovery 9.2.3. Predictive Toxicology 9.2.4. Others 9.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 9.3.1. Pharmaceutical & Biotechnology Companies 9.3.2. Research Organizations 9.3.3. Government & Academic Institutes 9.3.4. Others 10. North America Cell-Based Assays Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Cell-Based Assays Market Analysis and Forecasts, 2021-2029 11.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 11.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 11.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 12. Canada Cell-Based Assays Market Analysis and Forecasts, 2021-2029 12.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 12.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 12.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 13. Mexico Cell-Based Assays Market Analysis and Forecasts, 2021-2029 13.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 13.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 13.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 14. Europe Cell-Based Assays Market Analysis and Forecasts, 2021-2029 14.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 14.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 14.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 15. Europe Cell-Based Assays Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Cell-Based Assays Market Analysis and Forecasts, 2021-2029 16.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 16.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 16.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 17. France Cell-Based Assays Market Analysis and Forecasts, 2021-2029 17.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 17.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 17.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 18. Germany Cell-Based Assays Market Analysis and Forecasts, 2021-2029 18.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 18.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 18.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 19. Italy Cell-Based Assays Market Analysis and Forecasts, 2021-2029 19.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 19.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 19.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 20. Spain Cell-Based Assays Market Analysis and Forecasts, 2021-2029 20.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 20.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 20.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 21. Sweden Cell-Based Assays Market Analysis and Forecasts, 2021-2029 21.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 21.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 21.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 22. CIS Countries Cell-Based Assays Market Analysis and Forecasts, 2021-2029 22.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 22.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 22.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 23. Rest of Europe Cell-Based Assays Market Analysis and Forecasts, 2021-2029 23.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 23.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 23.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 24. Asia Pacific Cell-Based Assays Market Analysis and Forecasts, 2021-2029 24.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 24.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 24.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 25. Asia Pacific Cell-Based Assays Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Cell-Based Assays Market Analysis and Forecasts, 2021-2029 26.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 26.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 26.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 27. India Cell-Based Assays Market Analysis and Forecasts, 2021-2029 27.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 27.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 27.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 28. Japan Cell-Based Assays Market Analysis and Forecasts, 2021-2029 28.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 28.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 28.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 29. South Korea Cell-Based Assays Market Analysis and Forecasts, 2021-2029 29.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 29.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 29.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 30. Australia Cell-Based Assays Market Analysis and Forecasts, 2021-2029 30.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 30.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 30.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 31. ASEAN Cell-Based Assays Market Analysis and Forecasts, 2021-2029 31.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 31.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 31.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 32. Rest of Asia Pacific Cell-Based Assays Market Analysis and Forecasts, 2021-2029 32.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 32.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 32.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 33. Middle East Africa Cell-Based Assays Market Analysis and Forecasts, 2021-2029 33.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 33.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 33.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 34. Middle East Africa Cell-Based Assays Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Cell-Based Assays Market Analysis and Forecasts, 2021-2029 35.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 35.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 35.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 36. GCC Countries Cell-Based Assays Market Analysis and Forecasts, 2021-2029 36.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 36.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 36.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 37. Egypt Cell-Based Assays Market Analysis and Forecasts, 2021-2029 37.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 37.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 37.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 38. Nigeria Cell-Based Assays Market Analysis and Forecasts, 2021-2029 38.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 38.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 38.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 39. Rest of ME&A Cell-Based Assays Market Analysis and Forecasts, 2021-2029 39.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 39.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 39.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 40. South America Cell-Based Assays Market Analysis and Forecasts, 2021-2029 40.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 40.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 40.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 41. South America Cell-Based Assays Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Cell-Based Assays Market Analysis and Forecasts, 2021-2029 42.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 42.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 42.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 43. Argentina Cell-Based Assays Market Analysis and Forecasts, 2021-2029 43.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 43.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 43.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 44. Rest of South America Cell-Based Assays Market Analysis and Forecasts, 2021-2029 44.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 44.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 44.3. Market Size (Value) Estimates & Forecast By End users, 2021-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Cell-Based Assays Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. DiscoverX Corporation 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Danaher Corporation 45.3.3. Becton 45.3.4. Bio-Rad Laboratories, Inc. 45.3.5. Corning Inc. 45.3.6. Merck KGaA 45.3.7. Cell Signalling Technology Inc. 45.3.8. Cisbio Bioassays 45.3.9. PerkinElmer Inc. 45.3.10. Dickinson and Company 45.3.11. Cell Biolabs Inc. 45.3.12. Macrogen Inc. 45.3.13. Thermo Fisher Scientific, Inc. 45.3.14. Promega Corporation 45.3.15. Lonza Group Ltd. 45.3.16. Other Key Players 46. Primary Key Insights